Bioplastics’ Capacity Credibility Gap: What Will Actually Scale by 2030?

Bioplastics producers have announced substantial capacity growth through 2030, often presenting large project pipelines as evidence that the market has reached an inflection point. But how much of this announced capacity will actually reach the market? Flashy headline figures obscure major differences in project maturity, regional momentum, demand development, and the competitiveness of individual materials. 

In this webinar, we argue that bioplastics do not face one common scale-up barrier. Each material has a different path to growth, shaped as much by project execution, cost, and demand as by technology. Using Lux Research’s risk-adjusted capacity analysis, we separate credible projects from early stage announcements and compare the outlook for drop-in, performance, and end-of-life bioplastics. We examine how feedstock access, project economics, policy support, and downstream demand will determine whether new capacity translates into sustained market growth by 2030. 

Organizations across the chemicals, plastics, and packaging value chains will gain insights into: 

• Which bioplastics have the most credible capacity growth pathways through 2030 

• How regional outlooks change after accounting for construction progress, financing, partnerships, and other execution signals 

• Where supply could outpace demand — and what producers and offtakers should prioritize in sourcing, product development, and investment decisions